Veeva Systems Reports 16.3% Revenue Growth, Acquires Rise Healthcare Tech

Veeva Systems Inc. reported strong financial performance for the three months ended April 30, 2026, with total revenues reaching $882.9 million, a 16.3% increase from $759.0 million in the same period last year. Subscription revenues, which accounted for approximately 83% of total revenues, rose to $730.2 million, up from $634.8 million, while professional services and other revenues increased to $152.8 million from $124.3 million. The company achieved a net income of $260.9 million, or $1.57 per diluted share, compared to $228.2 million, or $1.37 per diluted share, in the prior year.

The company experienced notable changes in its financial metrics compared to the previous fiscal period. Gross profit increased to $662.0 million, representing a gross margin of 75%, down from 77% in the prior year. Operating income also rose to $273.1 million, up from $233.7 million, reflecting increased operating expenses primarily driven by higher research and development costs, which rose to $208.3 million from $184.0 million. The increase in operating expenses was attributed to higher employee compensation and benefits, as well as investments in product development.

Strategically, Veeva Systems made significant moves during the quarter, including the acquisition of Rise Healthcare Tech, Inc. (Ostro) for $90 million. Ostro provides an AI-driven engagement platform for life sciences, which is expected to enhance Veeva's offerings. The company also reported an increase in customer count, serving 1,552 customers as of April 30, 2026, up from 1,477 a year earlier. This growth was driven by expanding usage among existing customers and the addition of new clients, particularly in the R&D and Quality Solutions segment.

Operationally, Veeva's geographic expansion continued, with North America contributing 60% of subscription revenues, followed by Europe at 29% and Asia Pacific at 11%. The company reported a total cash, cash equivalents, and short-term investments balance of $7.3 billion as of April 30, 2026, providing a strong liquidity position to support future growth initiatives. Employee headcount increased to support the growing demand for its solutions, with a focus on enhancing customer engagement and product development.

Looking ahead, Veeva Systems anticipates continued growth in subscription revenues, particularly from its R&D and Quality Solutions. The company expects to invest further in product development and customer support, which may lead to increased operating expenses. However, management remains optimistic about the long-term potential of its solutions and the overall market for life sciences technology, despite potential challenges from competition and regulatory changes.